- IUCT Oncopole/
- Receiving care/
- Specialties/
- ENT cancers/
- Palmarès Le Point, Toulouse à l’honneur
Centre expert régional clinique INCa
- Cancers réfractaires de la thyroïde – Réseau TUTHYReF - Référent : Dr Slimane Zerdoud
- Cancers ORL rares – Réseau ReFCOR - Référent : Pr Sébastien Vergez
Back
Palmarès Le Point, Toulouse à l’honneur
Palmarès Le Point, Toulouse à l’honneur
L'IUCT-Oncopole est :
- 2e pour la prise en charge des cancers ORL (2e en 2020)
- 5e pour la chirurgie des cancers du sein (4e en 2020)
- 5e pour la prise en charge des leucémies de l'adulte (5e en 2020)
- 5e pour la prise en charge des lymphomes et myélomes (11e en 2020).
- 5e pour la chirurgie des cancers de l’ovaire (nouveauté 2021)
- 6e pour la chirurgie des cancers de l’utérus (nouveauté 2021)
- 9e pour la prise en charge des cancers de la peau (8e en 2020)
- 12e pour la chirurgie des sarcomes des tissus mous (7e en 2020)
« Nous nous maintenons dans le top 5 dans la plupart de nos spécialités : ORL, cancers féminins, hémopathies malignes (leucémie, lymphome et myélome), cancers de la peau et sarcomes. Ce qui témoigne de la dynamique collective à l'œuvre sur le site de l'Oncopole, souligne le Pr Jean-Pierre Delord. Je tiens à féliciter tout le personnel de l’IUCT-O pour leurs efforts et leur engagement. »
Les localisations prises en charge par le CHU de Toulouse (Rangueil/Larrey et Purpan) :
- Tumeurs du cerveau (Purpan) : 4e (4e en 2020)
- Cancers de la thyroïde (Rangueil/Larrey) : 6e (7e en 2020)
- Chirurgie des cancers osseux (Purpan) : 6e (2e en 2020)
- Cancers de la prostate (Rangueil/Larrey) : 2e (4e en 2020)
- Cancers du poumon (Rangeuil/Larrey) : 18e (14e en 2020)
- Cancers côlon ou intestin (Rangueil/Larrey) : 7e (28e en 2020)
- Cancers de l'estomac ou de l'œsophage (Rangueil/Larrey) : 10e (7e en 2020)
- Cancers du rein (Rangueil/Larrey) : 4e (8e en 2020)
- Cancers du foie (Rangueil/Larrey) : 12e (nouveauté 2021)
- Cancers de la vessie (Rangueil/Larrey) : 21e (23e en 2020)
- Cancers du pancréas (Rangueil/Larrey) : 8e (nouveauté 2021)
Head and neck cancers
The IUCT-Oncopole treats cancers affecting the head and the neck, including cancers of the nose, mouth, throat (pharynx and larynx) and ears. Most of these cancers are squamous cell carcinomas.
| Coordinating physicians: CONTACTS Specific follow-up and complex cases |
Head and Neck Coordination Committee
The Head and Neck Coordination Committee consists of a group of specialists that examines every case and decides on the most appropriate therapies and treatment pathways to offer each patient, whichever specialties the treatment calls upon.
The committee also fosters innovation by suggesting possible avenues for developing new diagnostic techniques and therapies, and by conducting clinical trials.
Collaboration with the CRCT
And with the CIRIMAT laboratory (UMR CNRS INPT UPS 5085 – Prof. C. Laurent)
Patient pathways
The first step in treating patients with cancer is to do a complete workup combining scan results (at least a CT scan of the neck and thorax, after injection of a contrast material) with an endoscope examination, carried out under general anesthetic. The endoscope examination is used to determine the stage of the tumor, take biopsy samples and choose the most appropriate therapy.
In some cases an MRI and/or PET scan may be necessary.
Personalized treatment program
Head and neck surgeons, radiation therapists, oncologists and radiologists examine the results of each patient’s workup at a weekly multidisciplinary team meeting, so they can decide on a personalized treatment program for each patient. They then present this program, together with any alternatives, to the patient during a special consultation held in conjunction with the patient’s family doctor.
Treatment
Treatment for head and neck tumors may involve:
- Surgery
- Radiotherapy
- Chemotherapy
Administered either alone or in combination.
Supportive care
Supportive care is available throughout the treatment period, from diagnosis to post-treatment. Services include speech therapy, dental treatment, nutrition, physiotherapy, and help in overcoming tobacco and other addictions. In addition, the cancer rehabilitation team will evaluate and help you overcome any impacts the disease and its treatment may have on swallowing and/or speech.
Follow up
Once treatment has been completed, follow-up consultations are held at regular intervals to check that the disease is under control and to treat any after effects of the disease and its treatment.
At any stage in your treatment, you may be asked whether you would like to take part in a clinical research project.